Skip to main content
CCSB logo

CCSB — Investor Relations & Filings

Ticker · 1762 ISIN · TW0001762003 TW Manufacturing
Open in API
Filings indexed 1,610 across all filing types
Latest filing 2019-07-10 Major Shareholding Noti…
Country TW Taiwan
Listing TW 1762

About CCSB

www.ccsb.com.tw

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB) is a specialized manufacturer of Active Pharmaceutical Ingredients (APIs) with a history dating back to 1964. The company focuses on the research, development, and large-scale production of high-quality APIs, particularly in the therapeutic areas of oncology, antifungal treatments, and immunosuppressants. CCSB offers a broad service portfolio that includes cGMP-compliant contract manufacturing and toll manufacturing. By leveraging advanced chemical synthesis and biotechnology platforms, the company provides tailored solutions to global pharmaceutical partners. CCSB adheres to rigorous international quality standards and environmental, health, and safety protocols, ensuring the reliable supply of critical medicinal components for the global healthcare market.

Recent filings

Filing Released Lang Actions
108年06月董事會成員及持股
Major Shareholding Notification Classification · 95% confidence The document contains detailed tabular data about shareholdings of company insiders, including directors, managers, and related parties. It lists the number of shares held, pledged shares, and related percentages. The content focuses on insider shareholdings and their changes, which is typical of a Director's Dealing or insider shareholding notification. There is no indication of financial results, audit information, meeting materials, or legal proceedings. The document is relatively short (2698 characters) and is a direct disclosure of insider shareholdings rather than an announcement or a report publication. Therefore, the most appropriate classification is Major Shareholding Notification (MRQ).
2019-07-10 Chinese
108年6月營業收入
Fund Information / Factsheet Classification · 95% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 中化生 for the period 民國108年06月 (June 2019). It includes numerical data on revenue changes compared to the previous year and explanatory notes about accounting standards (IFRS) and reporting practices. The document is very short (770 characters) and contains no detailed financial statements, management discussion, or comprehensive analysis. It is essentially a brief financial summary or factsheet rather than a full report or announcement of a report. There is no indication of it being an earnings release, annual or interim report, or any regulatory filing. Given the brief nature and summary style, the best fitting category is Fund Information / Factsheet (FS).
2019-07-10 Chinese
108年6月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 中化生, reporting on the status of fund loans and endorsement guarantees for the current and previous month, with amounts all zero. It contains no detailed financial statements or analysis, no mention of a report being attached or published, and no regulatory certifications. The content is a routine regulatory disclosure about financing and guarantees, fitting best under general regulatory announcements rather than a full financial report or announcement of a report. Therefore, it is classified as a Regulatory Filing (RNS).
2019-07-10 Chinese
因本公司有價證券於集中交易市場達公布注意交易資訊標準， 故公布相關財務業務等重大訊息，以利投資人區別瞭解。
Regulatory Filings Classification · 95% confidence The document is a short announcement from a listed company (1762 中化生) providing financial and business information due to reaching a disclosure threshold on the Taiwan Stock Exchange. It includes recent financial figures such as revenue, pre-tax profit, net profit, and EPS for recent periods, but it is brief (1334 characters) and does not contain comprehensive financial statements or detailed analysis. It is not a full quarterly or annual report but a regulatory disclosure of material financial information. The document also references compliance with Taiwan Stock Exchange disclosure rules and states no major events requiring further explanation. Given the short length and nature of the content, this fits best as a Regulatory Filing (RNS) rather than a full Interim Report (IR) or Earnings Release (ER).
2019-07-03 Chinese
108年06月法人說明會簡報 — 176220190628E001.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled 'First Quarter 2019 Investor Conference June 28, 2019' and contains detailed financial and operational results for Q1 2019, including consolidated income statements and balance sheets. It also includes market overview, business outlook, and future plans. The presence of detailed financial data for a quarterly period and the nature of the content indicate this is a comprehensive quarterly financial report rather than a brief earnings release or a simple announcement. The document length is 4860 characters, which is sufficient to contain substantive financial data and analysis. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q1 2019
2019-06-28 Chinese
108年06月法人說明會簡報 — 176220190628M001.pdf
Investor Presentation Classification · 95% confidence The document is titled as a "2019年第一季法人說明會" which translates to "2019 Q1 Institutional Investor Presentation". It contains detailed financial data such as consolidated income statements and balance sheets for Q1 2019, comparisons with previous quarters and years, market overview, product distribution, and future outlook. The presence of detailed financial tables and operational commentary indicates this is a presentation aimed at investors covering quarterly performance and strategic outlook. The document length is about 4994 characters, which is sufficient for a detailed presentation but not a full annual or interim report. There is no indication that this is a transcript of a call, an audit report, or a regulatory filing. The content matches the definition of an Investor Presentation (IP) which focuses on financials, strategy, and market position for investors.
2019-06-28 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.